U.S. Department of Agriculture, Agricultural Research Service, Eastern Regional Research Center, 600 East Mermaid Lane, Wyndmoor, PA 19038, USA.
J Chromatogr A. 2013 Oct 25;1313:103-12. doi: 10.1016/j.chroma.2013.08.103. Epub 2013 Sep 8.
A high-throughput qualitative screening and identification method for 9 aminoglycosides of regulatory interest has been developed, validated, and implemented for bovine kidney, liver, and muscle tissues. The method involves extraction at previously validated conditions, cleanup using disposable pipette extraction, and analysis by a 3 min ultrahigh-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method. The drug analytes include neomycin, streptomycin, dihydrosptreptomycin, and spectinomycin, which have residue tolerances in bovine in the US, and kanamicin, gentamicin, apramycin, amikacin, and hygromycin, which do not have US tolerances established in bovine tissues. Tobramycin was used as an internal standard. An additional drug, paromomycin also was validated in the method, but it was dropped during implementation due to conversion of neomycin into paromomycin. Proposed fragmentation patterns for the monitored ions of each analyte were elucidated with the aid of high resolution MS using a quadrupole-time-of-flight instrument. Recoveries from spiking experiments at regulatory levels of concern showed that all analytes averaged 70-120% recoveries in all tissues, except hygromycin averaged 61% recovery. Lowest calibrated levels were as low as 0.005 μg/g in matrix extracts, which approximately corresponded to the limit of detection for screening purposes. Drug identifications at levels <0.05 μg/g were made in spiked and/or real samples for all analytes and tissues tested. Analyses of 60 samples from 20 slaughtered cattle previously screened positive for aminoglycosides showed that this method worked well in practice. The UHPLC-MS/MS method has several advantages compared to the previous microbial inhibition screening assay, especially for distinguishing individual drugs from a mixture and improving identification of gentamicin in tissue samples.
一种高通量定性筛选和鉴定监管关注的 9 种氨基糖苷类药物的方法已经开发、验证并应用于牛肾、肝和肌肉组织。该方法包括在先前验证的条件下进行提取,使用一次性移液管萃取进行净化,以及通过 3 分钟超高效液相色谱-串联质谱(UHPLC-MS/MS)方法进行分析。药物分析物包括新霉素、链霉素、二氢链霉素和大观霉素,这些药物在美国牛组织中具有残留容忍度,而卡那霉素、庆大霉素、阿米卡星、氨曲南和潮霉素在美国牛组织中没有建立容忍度。妥布霉素被用作内标。另一种药物巴龙霉素也在该方法中得到了验证,但在实施过程中由于新霉素转化为巴龙霉素而被放弃。在使用四极杆飞行时间仪器的高分辨率 MS 的帮助下,阐明了每个分析物监测离子的建议碎裂模式。在监管关注水平的加标实验中的回收率表明,除了潮霉素的平均回收率为 61%外,所有分析物在所有组织中的平均回收率为 70-120%。基质提取物中最低校准水平低至 0.005 μg/g,这大约相当于筛查目的的检测限。在所有测试的分析物和组织中,在<0.05 μg/g 的水平下进行了加标和/或实际样品的药物鉴定。对先前筛选出氨基糖苷类药物阳性的 20 头屠宰牛的 60 个样本进行分析表明,该方法在实践中效果良好。与先前的微生物抑制筛选测定法相比,UHPLC-MS/MS 方法具有几个优点,特别是用于区分混合物中的个别药物并提高组织样品中庆大霉素的鉴定。